Influence of valproic acid on hepatic carbohydrate and lipid metabolism

Archives of Biochemistry and Biophysics
C M Becker, R A Harris

Abstract

Valproic acid (dipropylacetic acid), an antiepileptic agent known to be hepatotoxic in some patients, caused inhibition of lactate gluconeogenesis, fatty acid oxidation, and fatty acid synthesis by isolated hepatocytes. The latter process was the most sensitive to valproic acid, 50% inhibition occurring at ca. 125 microM with cells from meal-fed female rats. The medium-chain acyl-CoA ester fraction was increased whereas coenzyme A (CoA), acetyl-CoA, and the long chain acyl-CoA fractions were decreased by valproic acid. The increase in the medium chain acyl-CoA fraction was found by high-pressure liquid chromatography to be due to the accumulation of valproyl-CoA plus an apparent CoAester metabolite of valproyl-CoA. Salicylate inhibited valproyl-CoA formation and partially protected against valproic acid inhibition of hepatic metabolic processes. Octanoate had a similar protective effect, suggesting that activation of valproic acid in the mitosol is required for its inhibitory effects. It is proposed that either valproyl-CoA itself or the sequestration of CoA causes inhibition of metabolic processes. Valproyl-CoA formation also appears to explain valproic acid inhibition of gluconeogenesis by isolated kidney tubules. No evidence...Continue Reading

References

Jan 17, 1977·Clinica Chimica Acta; International Journal of Clinical Chemistry·D GompertzT Baillie
Apr 26, 1979·The New England Journal of Medicine·F J SuchyK E Bove
Jul 1, 1979·The Journal of Pediatrics·N GerberJ C Schimschock
Mar 1, 1975·Pediatric Research·A M Glasgow, H P Chase
May 1, 1970·Archives of Biochemistry and Biophysics·C L Moore, F F Jöbsis
Dec 1, 1966·Analytical Biochemistry·H Moellering, W Gruber
Jan 1, 1982·Toxicology·A C BeynenM J Geelen
Mar 20, 1980·The New England Journal of Medicine·J Koch-Weser, T R Browne
Jun 1, 1981·Pediatric Research·F X CoudeP P Kamoun
Apr 15, 1982·Biochemical Pharmacology·J BenavidesF Valdivieso
Mar 1, 1981·Contact Dermatitis·E W ClarkD S Wilkinson
Jan 1, 1962·The Biochemical Journal·D H WILLIAMSONH A KREBS

❮ Previous
Next ❯

Citations

Feb 22, 2001·Analytical Biochemistry·M F SilvaR J Wanders
Jan 1, 1995·Journal of Inherited Metabolic Disease·D RabierP Kamoun
Jun 19, 1992·Pharmaceutisch Weekblad. Scientific Edition·J R Stephens, R H Levy
Jun 19, 1992·Pharmaceutisch Weekblad. Scientific Edition·T A Baillie
Jan 1, 1990·European Journal of Clinical Pharmacology·F M WilliamsM D Rawlins
Apr 9, 2008·Journal of Inherited Metabolic Disease·M F B SilvaI Tavares de Almeida
Nov 15, 1985·Archives of Biochemistry and Biophysics·M E Steinhelper, M S Olson
Nov 1, 1990·Biochemical Pharmacology·K Veitch, F Van Hoof
Jan 1, 1990·Biochemical Pharmacology·I RozasS Rodriguez-Segade
Jul 15, 1991·Biochemical Pharmacology·D M CyrG C Tremblay
Jun 21, 1991·Biochemical Pharmacology·D J PorubekT A Baillie
Jul 22, 1992·Biochemical Pharmacology·B J Roberts, K M Knights
Mar 1, 1994·Chemico-biological Interactions·E P Brass
Jan 15, 1985·Clinica Chimica Acta; International Journal of Clinical Chemistry·D S MillingtonD J Liberato
Jan 1, 1988·The International Journal of Biochemistry·K H MooreF P Schreefel
Jan 1, 1995·Pharmacology & Therapeutics·B Fromenty, D Pessayre
Nov 1, 1993·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·P BentleyH J Wiegand
Aug 1, 1990·Toxicology·R M WalkerG E Macallum
Mar 1, 1990·Pediatric Neurology·G N Breningstall
Aug 11, 1998·Biochemical Pharmacology·A Siafaka-KapadaiM Javors
Jan 1, 1997·Life Sciences·J P Bolaños, J M Medina
Jan 3, 1987·Lancet·P P Kamoun, D Rabier
Mar 27, 2003·Pediatric Neurology·Eva L W FungTai Fai Fok
Mar 7, 2002·The Biochemical Journal·Margarida F B SilvaRonald J A Wanders
Jun 3, 1993·The New England Journal of Medicine·J H Thurston, R E Hauhart
Sep 1, 1986·Epilepsia·M C LaubG Jaeger
Jan 1, 1987·Epilepsia·N C Margaretten, R P Warren
Sep 1, 1988·Epilepsia·D ScheffnerS Unkelbach
Sep 1, 1994·Epilepsia·M A VanceK G Tolman
Apr 1, 1986·Journal of Neurology, Neurosurgery, and Psychiatry·D M TurnbullK G Alberti

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.